The 12 closest competitors and alternatives to Drizzle Health, LLC among diagnostics companies — ranked by similarity to what Drizzle Health, LLC actually does, not by market-cap band.
Subscribe to see Drizzle Health, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Drizzle Health develops sample concentration technology using patented tunable polymers to improve the sensitivity of diagnostic tests across food safety, clinical diagnostics, and biosecurity. The company offers products such as MagnaSlide for microscopy and MagnaFlow for inline processing to capture and concentrate target pathogens without the need for overnight enrichment.
Drizzle Health, LLC is a diagnostics company headquartered in United States. Its most recent funding round raised $500,000 in November 2024. Xcout tracks 6 named people at Drizzle Health, LLC, including Digvijay Singh (President).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $500,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Drizzle Health, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Food Safety & Diagnostics
SnapDNA provides rapid molecular diagnostic systems for food safety testing to help food companies detect pathogens like Listeria, Salmonella, and E. coli in approximately one hour. Their self-contained, cloud-connected instruments enable on-site, quantitative analysis of live cells without requiring a laboratory or specialized technical skills.
Biotechnology
MicroVizual Inc. develops a tape-based infrastructure platform that automates and digitizes histology workflows for research and clinical environments. The company's proprietary technology replaces traditional glass slides with continuous roll media to improve sample handling, throughput, and AI-readiness in pathology.
Medical Diagnostics
Immy Inc. develops, manufactures, and distributes diagnostic tests, reagents, and processing systems specializing in mycology. The company serves healthcare professionals, reference laboratories, and hospital settings by providing lateral flow assays, enzyme immunoassays, and PCR tests for the detection of fungal diseases.
Biotechnology
GNA Biosolutions GmbH is a German biotechnology company developing rapid molecular-diagnostics systems, including instruments and consumables for automated nucleic-acid extraction and amplification. Its solutions are intended for applications such as clinical testing, research, and other settings requiring fast pathogen or genetic analysis.
Biotech
Sansure Biotech Inc., founded in Changsha, China, in 2008, is dedicated to the global development and commercialization of advanced diagnostic and research products. The company offers a diverse range of solutions, including upstream nucleic acid extraction kits, real-time PCR systems for both clinical and investigative purposes, and fluorescence detection platforms. Their extensive product portfolio encompasses diagnostic assays for critical conditions like the novel coronavirus, viral hepatitis, and AIDS. Furthermore, they provide blood screening and general extraction kits, tests for cancer-related biomarkers, and solutions for respiratory, sexually transmitted, digestive tract, prenatal, postnatal, and genetic diseases. Sansure Biotech also supplies essential laboratory instrumentation and various consumables, primarily serving hospitals and scientific laboratories worldwide.
Biotechnology
Adarza BioSystems, Inc. is a biotechnology company headquartered in St. Louis, Missouri, focused on label-free detection biosystems and life sciences solutions.
Biotech
Detechgene is a Cologne, Germany-based biotechnology company founded in 2022 that specializes in molecular diagnostics and life sciences. The company develops rapid molecular testing platforms and cartridge systems designed for the precise detection of pathogens.
Life Sciences
Nimble Science is a digital health and precision medicine company headquartered in Calgary, Canada, that delivers small intestine sampling technology and multi-omic data.
Biotechnology
Intus Biosciences develops proprietary microbiome analysis technology that combines patented science, long-read sequencing, and AI to deliver strain-level resolution of microbial data. The company serves healthcare providers, researchers, and consumers through clinical-grade profiling products like GutID and research partnerships aimed at drug development and biomarker discovery.
Biotechnology
Countable Corp. (operating as Countable Labs) develops and manufactures instruments, assays, and platforms for high-precision PCR DNA and RNA detection. Serving researchers, clinical laboratories, and life sciences organizations, the company provides tools for rare event detection, cell and gene therapy, and molecular diagnostics.
Biotechnology
StabiLux Biosciences develops high-brightness dye technology utilizing boron nitride nanoparticles for biomedical applications. The company's platform supports antibodies, RNA, and proteins to help researchers detect biomarkers for early cancer detection, drug discovery, mRNA vaccines, and immunology.
Biotech
Slingshot Biosciences, Inc. develops synthetic biology-based biomimetic cells and cell-like materials that replicate key properties of biological cells. Its products serve life-science researchers, diagnostic developers, and clinical laboratory and instrument manufacturers for applications such as assay development, quality control, and instrument validation.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Drizzle Health, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →